Literature DB >> 26331822

Chinese consensus on early diagnosis of primary lung cancer (2014 version).

Jie Hu1, Gui-Sheng Qian2, Chun-Xue Bai1,3.   

Abstract

The incidence and mortality of lung cancer in China have rapidly increased. Lung cancer is the leading cause of cancer death in China, possibly because of the inadequate early diagnosis of lung cancer. Reaching a consensus on early diagnostic strategies for lung cancer in China is an unmet needed. Recently, much progress has been made in lung cancer diagnosis, such as screening in high-risk populations, the application of novel imaging technologies, and the use of minimally invasive techniques for diagnosis. However, systemic reviews of disease history, risk assessment, and patients' willingness to undergo invasive diagnostic procedures also need to be considered. A diagnostic strategy for lung cancer should be proposed and developed by a multidisciplinary group. A comprehensive evaluation of patient factors and clinical findings should be completed before treatment.
© 2015 American Cancer Society.

Entities:  

Keywords:  bronchoscopy; diagnosis; lung cancer; screening

Mesh:

Year:  2015        PMID: 26331822     DOI: 10.1002/cncr.29571

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Tumour growth-suppressive effect of arsenic trioxide in squamous cell lung carcinoma.

Authors:  Leanne Lee Leung; Sze-Kwan Lam; Yuan-Yuan Li; James Chung-Man Ho
Journal:  Oncol Lett       Date:  2017-07-21       Impact factor: 2.967

2.  Support Vector Machine for Lung Adenocarcinoma Staging Through Variant Pathways.

Authors:  Feng Di; Chunxiao He; Guimei Pu; Chunyi Zhang
Journal:  G3 (Bethesda)       Date:  2020-07-07       Impact factor: 3.154

3.  Circulating Tumor Cells as a Biomarker to Assist Molecular Diagnosis for Early Stage Non-Small Cell Lung Cancer.

Authors:  Yutong He; Jin Shi; Bernd Schmidt; Qingyi Liu; Gaofeng Shi; Xiaoli Xu; Congmin Liu; Zhaoyu Gao; Tiantian Guo; Baoen Shan
Journal:  Cancer Manag Res       Date:  2020-02-05       Impact factor: 3.989

4.  Role of circulating tumor cells in diagnosis of lung cancer: a systematic review and meta-analysis.

Authors:  Qingtao Zhao; Zheng Yuan; Huien Wang; Hua Zhang; Guochen Duan; Xiaopeng Zhang
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

Review 5.  Early diagnosis of lung cancer: which is the optimal choice?

Authors:  Jing Ning; Tao Ge; Minlin Jiang; Keyi Jia; Lei Wang; Wei Li; Bin Chen; Yu Liu; Hao Wang; Sha Zhao; Yayi He
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

6.  Comorbidity in lung cancer patients and its association with hospital readmission and fatality in China.

Authors:  Dawei Zhu; Ruoxi Ding; Yong Ma; Zhishui Chen; Xuefeng Shi; Ping He
Journal:  BMC Cancer       Date:  2021-05-17       Impact factor: 4.430

7.  Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China.

Authors:  YangBo Hu; Huan Hu; LiYun Miao; Xin Zhao; Wei Gu; Wei Heng; ZiLi Meng; Jian Feng; Yi You; XingXiang Xu; Rong Hu; HaiQuan Li; Jie Zhao; XiaoLi Zhu; MeiQi Shi; Li Shen; XiuWei Zhang; XiaoWei Yin; Hang Ma; MinHua Shi; Yong Yu; Hong Lv; LiMing Cai; GaoHua Feng; YeQing Zhang; Feng Wu; TangFeng Lv; Yong Song
Journal:  Thorac Cancer       Date:  2018-01-17       Impact factor: 3.500

8.  DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis.

Authors:  Chenzi Zhang; Wenjun Yu; Lin Wang; Mingna Zhao; Qiaomei Guo; Shaogang Lv; Xiaomeng Hu; Jiatao Lou
Journal:  J Cancer       Date:  2017-09-30       Impact factor: 4.207

9.  Clinical characteristics and work-up of small to intermediate-sized pulmonary nodules in a Chinese dedicated cancer hospital.

Authors:  Xiaonan Cui; Daiwei Han; Marjolein A Heuvelmans; Yihui Du; Yingru Zhao; Lei Zhang; Harry J M Groen; Geertruida H de Bock; Monique D Dorrius; Matthijs Oudkerk; Rozemarijn Vliegenthart; Zhaoxiang Ye
Journal:  Cancer Biol Med       Date:  2020-02-15       Impact factor: 4.248

10.  Status and Perspectives of Clinical Modes in Surgical Patients With Lung Cancer: A Retrospective Study.

Authors:  Yutian Lai; Heng Du; Xin Wang; Cheng Shen; Jian Huang; Weiming Li; Guowei Che
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.